Edgewise Therapeutics, Inc. (EWTX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $256.0K | -80.5% |
| 2024 | $1.31M | -77.2% |
| 2023 | $5.75M | +3.6% |
| 2022 | $5.55M | +730.2% |
| 2021 | $668.0K | +229.1% |
| 2020 | $203.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $256.0K | -80.5% |
| 2024 | $1.31M | -77.2% |
| 2023 | $5.75M | +3.6% |
| 2022 | $5.55M | +730.2% |
| 2021 | $668.0K | +229.1% |
| 2020 | $203.0K | — |